Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Sohanya Roshan Cheng files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard A. Paulson - $145K of KPTI open-market activity in the last 12 months
- Michael Klichinsky - $139K of CARM open-market activity in the last 12 months
- Stuart Poulton - $59K of KPTI open-market activity in the last 12 months
- Reshma Rangwala - $58K of KPTI open-market activity in the last 12 months
- Michael Mano - $37K of KPTI open-market activity in the last 12 months
- Lori Macomber - $10K of KPTI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Sohanya Roshan Cheng?
Sohanya Roshan Cheng is a corporate insider, tracked as EVP & Chief Commercial Officer of Karyopharm Therapeutics Inc. (KPTI). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Sohanya Roshan Cheng last file a Form 4?
The most recent primary Form 4 on record is dated 15 May 2026, one of 6 filings going back to 2024.
Has Sohanya Roshan Cheng been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($48K) across all tracked filings.
Where can I see all of Sohanya Roshan Cheng's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sohanya Roshan Cheng and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
